Only the oligomeric form was capable of rescuing tumor growth in PRMT1-depleted PDAC models, directly linking PRMT1’s structural state to its tumor-promoting function and highlighting the therapeutic potential of targeting its oligomeric assembly. This evidence concerns the gene PRMT1 and neoplasm.